These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16686332)

  • 21. Effects of antihypertensive drugs on blood pressure and proteinuria in childhood.
    Simonetti GD; Rizzi M; Donadini R; Bianchetti MG
    J Hypertens; 2007 Dec; 25(12):2370-6. PubMed ID: 17984655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological hypertension therapy].
    Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
    Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypertension by general practitioners and antihypertensive drugs expenditure in an urban environment.
    Marković BB; Kranjcević K; Stojanović-Spehar S; Blazeković-Milaković S; Kern J; Botica MV; Jelinić JD; Marković M
    Coll Antropol; 2009 Mar; 33(1):71-6. PubMed ID: 19408606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics of Hypertension Treatment.
    Rysz J; Franczyk B; Rysz-Górzyńska M; Gluba-Brzózka A
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacotherapeutical features of arterial hypertension in patients with diabetes mellitus].
    Okunevich IV; Khnychenko LK; Sapronov NS
    Klin Med (Mosk); 2007; 85(1):52-7. PubMed ID: 17419357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
    Volpe M; Tocci G
    J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are all the hypertensives made equal?
    Flaa A; Kjeldsen SE
    Herz; 2006 Jun; 31(4):323-30. PubMed ID: 16810472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
    Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
    Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 35. A common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older women.
    Moraes CF; Souza ER; Souza VC; Medeiros EF; Gonçalves TF; Toledo JO; Karnikowski M; Gomes L; Karnikowski MG; Córdova C; Nóbrega OT
    Clin Chim Acta; 2008 Oct; 396(1-2):70-5. PubMed ID: 18657531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systolic, diastolic and pulse pressure: therapeutic options].
    Montereggi A
    Ital Heart J Suppl; 2001 Apr; 2(4):375-80. PubMed ID: 19397010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics of blood pressure response to antihypertensive treatment.
    Mellen PB; Herrington DM
    J Hypertens; 2005 Jul; 23(7):1311-25. PubMed ID: 15942450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of renin: an updated review of the development of renin inhibitors.
    Li YC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.